Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

11 Results Found

Advisory
Member

Trump Administration Issues Order on Drug Pricing

The White House April 15 released an executive order, “Lowering Drug Prices by Once Again Putting Americans First,” directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
Guides/Reports
Public

2024 Costs of Caring

While recent data suggest that some hospital and health system finances have experienced modest stabilization from historic lows in 2022, the hospital field is still far from where it needs to be to meet the demand for care, invest in new and promising technologies and interventions, and stand ready for the next health care crisis.
Letter/Comment
Public

AHA Urges Administration to Grant Exceptions for Tariffs for Medications and Medical Supplies

The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the provision of safe, effective care in America's hospitals, clinics, and other settings.
News

Drug Prices and Shortages Jeopardize Patient Access to Quality Hospital Care

The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient o
Advocacy
Public

Affordability Advocacy Agenda

Our shared focus with Congress and Administration is on providing relief from the pandemic, ensuring a smooth recovery, and rebuilding a better health care system for the future. The American Hospital Association continues to incorporate principles that promote improved affordability, value, and equity into our policy and advocacy activities.
Letter/Comment
Public

AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions

AHA writes in support of H.J.Res. 139, a joint resolution for congressional disapproval of a rule relating to "Medicare and Medicaid Programs; Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting."
Guides/Reports
Public

2023 Costs of Caring

Hospitals appreciate the support and resources that Congress have provided throughout the COVID-19 pandemic; however, additional support is needed to keep hospitals strong so they can continue to provide care to patients and communities.
Blog

Flawed Report Aims to Deflect Attention From Role Insurer PBMs Play in High Drug Costs

A new AHIP “report” suggests that hospitals are significantly marking up the costs of drugs to the detriment of patients. They make baseless claims that specialty pharmacies, many of which insurers conveniently own through their pharmacy benefit manager (PBM) affiliates, provide a lower-cost alternative for patients.
News

Flawed Report Aims to Deflect Attention From Role Insurer PBMs Play in High Drug Costs

A new AHIP “report” suggests that hospitals are significantly marking up the costs of drugs to the detriment of patients. They make baseless claims that specialty pharmacies, many of which insurers conveniently own through their pharmacy benefit manager (PBM) affiliates, provide a lower-cost alternative for patients.
White Papers

Health Insurer Specialty Pharmacy Policies Threaten Patient Quality of Care

Regulators should prohibit health insurers from preventing hospitals and physicians in their networks from directly acquiring and storing drugs used in patient care. A number of large health insurers are requiring these providers to accept drugs purchased or handled by their own or affiliated pharmacies.